Viewing StudyNCT00359762



Ignite Creation Date: 2024-05-05 @ 4:56 PM
Last Modification Date: 2024-10-26 @ 9:26 AM
Study NCT ID: NCT00359762
Status: COMPLETED
Last Update Posted: 2015-09-15
First Post: 2006-07-31

Brief Title: Exenatide Versus Glimepiride in Patients With Type 2 Diabetes
Sponsor: AstraZeneca
Organization: AstraZeneca

Conditions & Keywords Data

Conditions:
Name
Type 2 Diabetes Mellitus
Keywords:
Name View
glimepiride View
exenatide View
diabetes View
Amylin View
Lilly View